Deciding on transplantation for myelofibrosis: Setting the record straight [3]

Mayo Clinic Proceedings

Volumn 79, Issue 7, 2004, Pages 953-954

  Tefferi, Ayalew ^a   Deeg, H Joachim ^b  

^a Mayo Clinic   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECISION MAKING; DISEASE COURSE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LETTER; MYELOFIBROSIS; MYELOID METAPLASIA; PATIENT SELECTION; PRACTICE GUIDELINE; QUALITY OF LIFE; RISK FACTOR; SURVIVAL RATE; TREATMENT INDICATION;

EID: 3042854224     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/79.7.953     Document Type: Letter

References (12)

1. Benesch M, Deeg HJ. Hematopoietic cell transplantation for adult patients with myelodysplastic syndromes and myeloproliferative disorders. Mayo Clin Proc. 2003;78:981-990.
2. Maziarz RT, Mesa RA, Tefferi A. Allogeneic stem cell transplantation for chronic myeloproliferative disorders and myelodysplastic syndromes: the question is "when?" [editorial]. Mayo Clin Proc. 2003;78:941-943.
3. Deeg HJ. The message is not the median! [letter]. Mayo Clin Proc. 2004;79;275.
4. Tefferi A. The message is not the median! [reply]. Mayo Clin Proc. 2004;79:275-276.
5. Cervantes F, Barosi G, Demory JL, et al. Myelofibrosis with myeloid metaplasia in young individuals: disease characteristics, prognostic factors and identification of risk groups. Br J Haematol. 1998;102:684-690.
6. Dupriez B, Morel P, Demory JL, et al. Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system. Blood. 1996;88:1013-1018.
7. Deeg HJ, Gooley TA, Flowers ME, et al. Allogeneic hematopoietic stem cell transplantation for myelofibrosis. Blood. 2003;102:3912-3918.
8. Guardiola P, Anderson JE, Gluckman E. Myelofibrosis with myeloid metaplasia [letter]. N Engl J Med. 2000;343:659.
9. Daly A, Song K, Nevill T, et al. Stem cell transplantation for myelofibrosis: a report from two Canadian centers. Bone Marrow Transplant. 2003;32:35-40.
10. Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med. 2000;342:1255-1265.
11. Popplewell LL, Forman SJ. Is there an upper age limit for bone marrow transplantation? Bone Marrow Transplant. 2002;29:277-284.
12. Devine SM, Hoffman R, Verma A, et al. Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia. Blood. 2002;99:2255-2258.